Immunovant’s (IMVT) Overweight Rating Reaffirmed at Cantor Fitzgerald
Immunovant (NASDAQ:IMVT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by equities research analysts at Cantor Fitzgerald in a research report issued to clients and investors on Wednesday, Benzinga reports. Several other equities analysts have also issued reports on the company. HC Wainwright restated a “buy” rating and set a $51.00 price target […]
More Stories
9 in 10 Canadians Over 45 Say They Want to Age at Home: Survey
By Chandra Philip A new survey found that 90 percent of Canadians aged 45 years and older would prefer to...
UnitedHealth Group (NYSE:UNH) Shares Down 15.3% Following Analyst Downgrade
UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report) traded down 15.3% on Thursday after Mizuho lowered their price target on...
BNP Paribas Financial Markets Raises Stock Holdings in VanEck Floating Rate ETF (NYSEARCA:FLTR)
BNP Paribas Financial Markets boosted its stake in shares of VanEck Floating Rate ETF (NYSEARCA:FLTR – Free Report) by 135.3%...
Sen. John Boozman Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)
Senator John Boozman (R-Arkansas) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on May 14th, the...
Baird Financial Group Inc. Buys New Position in Robinhood Markets, Inc. (NASDAQ:HOOD)
Baird Financial Group Inc. bought a new stake in Robinhood Markets, Inc. (NASDAQ:HOOD – Free Report) during the 4th quarter,...
DICK’S Sporting Goods’ (DKS) Outperform Rating Reaffirmed at Telsey Advisory Group
DICK’S Sporting Goods (NYSE:DKS – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Telsey Advisory...